Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Protara Therapeutics (TARA) Assets Average (2016 - 2026)

Protara Therapeutics' Assets Average history spans 13 years, with the latest figure at $200.7 million for Q1 2026.

  • Quarterly Assets Average rose 14.68% to $200.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $200.7 million through Mar 2026, up 14.68% year-over-year, with the annual reading at $195.5 million for FY2025, 50.12% up from the prior year.
  • Assets Average came in at $200.7 million for Q1 2026, up from $177.1 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $200.7 million in Q1 2026 to a low of $73.5 million in Q1 2024.
  • The 5-year median for Assets Average is $137.8 million (2024), against an average of $132.6 million.
  • Year-over-year, Assets Average plummeted 39.5% in 2023 and then soared 137.96% in 2025.
  • Protara Therapeutics' Assets Average stood at $130.9 million in 2022, then tumbled by 36.07% to $83.7 million in 2023, then skyrocketed by 64.58% to $137.8 million in 2024, then rose by 28.51% to $177.1 million in 2025, then increased by 13.35% to $200.7 million in 2026.
  • Per Business Quant, the three most recent readings for TARA's Assets Average are $200.7 million (Q1 2026), $177.1 million (Q4 2025), and $150.8 million (Q3 2025).